₹997.20
+60.20 (+6.42%)
As of 23 Sept 2026, Supriya Lifescience Ltd share price is ₹997.20. The stock opened at ₹997.20 and had closed at ₹937.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹545.65 and a high of ₹1,085.50. In terms of performance, Supriya Lifescience Ltd share price has increased by 66.02% over the past six months and has increased by 27.43% over the last year.
SUPRIYA Stock Price Chart
Supriya Lifescience Ltd Overview
Market cap₹7,541 Crs
Volume13,010
Prev. Close₹937.00
Year range₹545.65 - ₹1,085.50
ISININE07RO01027
About SUPRIYA
Supriya Lifesciences is primarily engaged in manufacturing of Bulk Drugs and Pharmaceutical Chemicals..
Supriya Lifescience Ltd Historical Performance
1 Month Return16.40%
6 Month Return70.10%
3 Year Return238.02%
3 Month Return1.08%
1 Year Return25.36%
5 Year Return-
Supriya Lifescience Ltd Fundamentals
ROCE(TTM)23.00%
P/E Ratio (TTM)38.01
P/B Ratio6.30
Debt to Equity0.00
ROE17.46%
EPS (TTM)24.69
Dividend Yield0.11%
Book Value148.82
Profit Margin22.77%
Operating Margin29.67%
Supriya Lifescience Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 839.37 | 706.31 | 581.01 | 470.43 | 537.63 |
| EBITDA | 305.08 | 270.61 | 183.61 | 138.39 | 221.57 |
| Net Profit | 209.12 | 187.96 | 119.11 | 89.86 | 151.81 |
| EPS | 25.98 | 23.35 | 14.80 | 11.16 | 18.86 |
Supriya Lifescience Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 923.57 |
| Resistance 1 (R1) | 960.22 |
| Pivot Point | 946.78 |
Supriya Lifescience Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 04-Sep-2026 | 27-May-2026 | 04-Sep-2026 | Final | ₹1.00 |
| 04-Sep-2025 | 27-May-2025 | 05-Sep-2025 | Final | ₹1.00 |
| 20-Sep-2024 | 28-May-2024 | 21-Sep-2024 | Final | ₹0.80 |
| 15-Sep-2023 | 26-May-2023 | 15-Sep-2023 | Final | ₹0.60 |
| 01-Sep-2022 | 20-May-2022 | 02-Sep-2022 | Final | ₹0.60 |
SUPRIYA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Satish Waman Wagh | Chairman & Managing Director |
| Satish Waman Wagh | Chairman & Managing Director |
| Satish Waman Wagh | Chairman & Managing Director |
Supriya Lifescience Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,849.40+0.16% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,391.50+0.42% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,933.50-0.03% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Supriya Lifescience Ltd today is ₹997.20 on NSE and ₹997.20 on BSE.
- The 52-week high of Supriya Lifescience Ltd is ₹1,085.50, while the 52-week low is ₹545.65.
- The current market capitalisation of Supriya Lifescience Ltd is approximately ₹7,541 crore.
- The P/E (Price-to-Earnings) ratio of Supriya Lifescience Ltd is 38.01. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Supriya Lifescience Ltd is 6.30. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Supriya Lifescience Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SUPRIYA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Supriya Lifescience Ltd has delivered a return of approximately 238.02%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Supriya Lifescience Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 68.30% promoters, 4.89% FIIs, 5.30% DIIs, and 15.98% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
